We're monitoring attitudes and behaviors during the pandemic. See Our Latest COVID-19 Survey Results

Schlesinger Group COVID-19 Update

We are successfully conducting Responsible In-Person Research. The Schlesinger COVID-19 Taskforce monitors in-person research outcomes to ensure we continue to conduct in-person research responsibly and effectively.

Risk-Free In-Person Studies

Researchers are planning and conducting in-person research. We have developed a Risk-Free Solution (valid until December 31, 2020) to support you:

  1. If you book facility rooms now and have to cancel, we will waive the standard room cancellation fees.
  2. When providing you with a quote to execute an in-person project, we will safeguard the project by including a quote to execute the project online. We will have recruited respondents who are willing and able to participate in-person or online. If we are unable to execute the work in-person due to safety or other concerns, the work can proceed online so you can meet your research objectives.
  3. And, even if we need to postpone or cancel the online version of the project, we will waive those fees, provided recruitment has not started.
  4. If you are unable or prefer not to travel to our facilities to view your study, we can book FocusVision streaming on your behalf at a special Schlesinger Group flat rate of $750 per day. This generous discount on FocusVision’s standard rate is valid with Schlesinger facility hire up to December 31st.
  5. If your multi-market research is impacted by changing travel restrictions, subject to availability, you are welcome to stay on and work from our facility, as we switch your study to an online solution.  
  6. If you require local moderators, we can support this.
  7. Our teams will continue to work with you to help overcome project challenges. Together, we will find a solution.

Our Facility Markets are Open

US: Atlanta | Baltimore | Boston | Charlotte | Chicago | Columbus | Dallas | Houston
Kansas City | Los Angeles* | Miami | Minneapolis | Nashville | New Jersey | New York | Orlando
Philadelphia | Phoenix | San Francisco* | St. Louis

SPAIN | GERMANY | UK*

* Open for essential research

icon

Updated Precautions for In-Person Studies

Download our latest statement on our preparedness for in-person studies, including how we are managing in-person respondent screening and have elevated facility standards for the protection of staff and visitors.

DOWNLOAD

icon

Important Travel Restrictions

As travel restrictions are gradually lifting across the globe, US states and countries have adopted local protocols and guidelines. Please allow for any restrictions or changes that may be applicable to your study planning.

We have found Delta Airlines to be an excellent resource for current information regarding security protocols, restrictions, and conditions across the US and internationally.

If any changes occur that impact your project, our team is on hand to work with you to overcome restrictions through solutions such as remote moderation, research streaming, local moderators sourcing, online qual platforms, and online research labs.

Ordered for In-Person Research

icon

40

Electrostatic Sanitizing Sprayers

icon

14,000

Face Masks

icon

5,230

Hand Sanitizers

icon

3,600

Disinfectant Wipe Packs

We are Here to Help

Whether you need in-person or online research, we are here to help in the planning and execution of your important studies.

Please contact your Account Manager or Info@SchlesingerGroup.com.

Contact in the USA

Laura Livers, EVP, Qualitative Solutions
Laura.Livers@SchlesingerGroup.com
+1 (678) 298-9230

Contact in the UK

Hanna Assouline, Managing Director
Hanna.Assouline@SchlesingerGroup.com
+44 207 487 9189

Contact in Germany

Stephan Lange, Managing Director
Stephan.Lange@SchlesingerGroup.com
+49-30-235096-15

Contact in Spain

Rosa Dalet, Managing Director
Rosa.Dalet@SchlesingerGroup.com
+34 934 155 228

Contact in France

Melanie Felix, Manager
Melanie.Felix@SchlesingerGroup.com
+ 33 (0) 1 70 64 83 56